TISSUE ACQUISITION and PROCUREMENT

tissue-amsbio
THE SERVICE PROVIDED BY AMSBIO

Recently developed custom acquisition protocols for collection of clinically-defines human specimens.
  • Obtaining frozen and viable cellular sub-fractions from blood and bone marrow (haematological malignancies).
  • Procurement of matching specimen sets from patients with solid tumours (tumour and adjacent normal tissues, serum/plasma, viable PBMCs, RNA, DNA, ect.).
  • Development of primary cell lines from solid tumours and normal tissues.
  • Collection of frozen and FFPE tumour specimens with follow-up date (colorectal cancer, breast cancer, glioblastoma, ect.).
  • Procurement of specimen sets (tissue biopsy, synovial fluid, PBMCs, serum, ect.) from patients with inflammatory diseases (rheumatoid arthritis, lupus, asthma, ect.).
  • Post-mortem collection of disease-targeted tissues from donors with neurological diseases (Parkinson’s disease, Alzheimer’s disease, and others).
  • Procurement of normal tissue sets for cross-reactivity testing.
  • AMS Biotechnology (Europe) Limited, Registered office: 184 Milton Park, Abingdon OX14 4SE, UK. VAT No. GB 502 2372 95. Reg. in England and Wales no. 2117791.
    Telephone: (UK) +44 1235 828 200 (CH) +41 91 604 55 22 (DE) +49 69 77 90 99,
    Usage of this web site is governed by our privacy policy ,our web site Terms and Conditions , our use of the web site Terms and Conditions and our Terms of Sale